Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
ID: 352546Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Feb 21, 2024 12:00 AM
  4. 4
    Due Jul 2, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)". This opportunity falls under the category of Income Security and Social Services. The grant is a Cooperative Agreement and does not require cost sharing or matching.

The purpose of this grant is to establish a Consortium that will provide resources, expertise, and coordination to advance innovative and high-quality research on palliative care for individuals with serious illnesses across their lifespan. The Consortium will focus on research related to Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs) within NIH.

The goals of this initiative include generating new scientific knowledge, supporting pilot and exploratory studies, fostering the development of early- and mid-career palliative care investigators, serving as a national platform for palliative care research resources, engaging healthcare systems and community-based organizations as research partners, and disseminating research findings and best practices to the palliative care research and clinical communities. The Consortium will also focus on addressing disparities in access, quality, and use of palliative care services for health disparities populations or in underserved areas.

The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) Entities (Foreign Organizations) and non-U.S. components of U.S. Organizations are not eligible to apply.

The closing date for this grant opportunity is July 2, 2024. For more information and to apply, please visit the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-002.html. If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
Files
Title
Posted
Similar Opportunities
NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional)". This opportunity falls under the category of Health and is a Cooperative Agreement funding instrument type. The grant does not require cost sharing or matching. The purpose of this grant is to support renewal and competing revision applications for U01 research project cooperative agreements focused on aging research. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territory or Possession. The closing date for this grant opportunity is October 1, 2024. For more information and to apply, please visit the following link: [Additional Information](http://grants.nih.gov/grants/guide/pa-files/PAR-22-362.html). If you have any inquiries, please refer to the contact information provided in Section VII. Agency Contacts within the full opportunity announcement.
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)". This grant aims to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The objective of this grant is to advance and improve the diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness. The grant does not require cost sharing or matching requirements and falls under the category of Income Security and Social Services. The maximum award ceiling is $1,000,000. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are also not eligible to apply. The grant opportunity will close on August 13, 2024, and the archive date is set for September 18, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-206.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-206.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)". This grant aims to support the development of novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. The grant does not require cost sharing or matching requirements and falls under the category of funding activity for health. The funding instrument type is a grant, and the opportunity category is discretionary. The CFDA number associated with this grant is 93.866. The eligible applicants for this grant include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. The grant has a closing date of December 2, 2025, and an award ceiling of $500,000. The description of the grant emphasizes the need for interdisciplinary partnerships or collaborations to develop research infrastructure that will advance the science of aging. For more information and to apply for this grant opportunity, interested parties can visit the following website: [http://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-054.html). Any additional inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research. This funding opportunity supports large-scale, complex research projects focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). The projects are expected to involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions. The research will address one or more AD/ADRD implementation research milestones supporting the research goals of the National Plan to Address Alzheimer's and Related Dementias. The opportunity does not require cost sharing or matching. Other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic (non-U.S.) entities (foreign organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities (foreign institutions) and non-domestic components of U.S. organizations are not eligible to apply. The closing date for applications is October 17, 2024. For more information, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-077.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-077.html). For any inquiries, please contact NIH OER Webmaster at OERWebmaster03@od.nih.gov.
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research. This funding opportunity supports large-scale, complex research programs focused on Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). The programs are expected to involve a team of investigators within a single institution or a consortium of institutions and align with one or more AD/ADRD implementation research milestones supporting the research goals of the National Plan to Address Alzheimer's and Related Dementias. The opportunity is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic entities and components are not eligible to apply. The closing date for applications is September 25, 2024. For more information, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-110.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-110.html). For any inquiries, please refer to the contact information provided in the full opportunity announcement.